Celularity Inc. Form 8-K Filing Summary

This Form 8-K filing by Celularity Inc. reports on the company's Annual Meeting of Stockholders held on December 19, 2025. Three proposals were voted on: election of Class I Directors, ratification of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and an amendment to the 2021 Equity Incentive Plan to increase the number of shares available for awards. Stockholders elected Peter Diamandis, Diane Parks, and Geoffrey Ling to the Board of Directors. The appointment of EisnerAmper LLP was ratified. However, the amendment to increase the shares available under the equity incentive plan was not approved. The filing also includes details on the voting results for each proposal, including votes for, against, abstentions, and broker non-votes. The company also confirmed its status as an emerging growth company and its election not to use the extended transition period for new or revised financial accounting standards.